News
3h
Zacks.com on MSNCRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on ItCRISPR Therapeutics (CRSP) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the 10 Stocks Going Wild. Crispr Therapeutics rallied for a second day on ...
Analysts have also weighed in on stock throughout the month. Recent analyst calls on the stock include: Needham analyst Gil ...
Names including Kohls, Plug Power, and Mara Holdings round out the list of the market's top 10 most-shorted stocks.
The anti-GPC3 targeted therapies market is expected to witness growth in the coming years, driven by the increasing incidence of cancer cases, clinical pipeline activity, and anticipated regulatory ...
2don MSN
A Ph.D. student in biomolecular engineering at the University of California, Santa Cruz, has built a software program ...
Mr. Mahatme brings decades of experience in strategic finance, capital formation, and operational leadership to support ...
6d
TipRanks on MSNCrispr Therapeutics AG Stock Soars Amid Clinical AdvancesCrispr Therapeutics AG ( ($CRSP) ) has risen by 7.26%. Read on to learn why. Crispr Therapeutics AG has seen a notable ...
ARK Innovation ETF (BATS: ARKK) is pushing to fresh 52-week highs Thursday, buoyed by strong performances from its key ...
With half a million people having already received multi-cancer early detection (MCED) screening, patients are and will continue to be asking about these blood tests during their visits, physicians ...
UC Berkeley and Caltech researchers identified a gene circuit in zebrafish that allows heart regeneration after injury. Using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results